Bio-Rad Laboratories (BIO-B) Free Cash Flow (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Free Cash Flow data on file, last reported at $78.1 million in Q1 2026.

• Quarterly Free Cash Flow fell 18.22% year-over-year to $78.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $357.2 million (changed 0.48% YoY) and the FY2025 annual result came in at $374.6 million, up 29.35% from the prior year.
• Free Cash Flow fell to $78.1 million in Q1 2026 per BIO-B's latest filing, from $119.1 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $123.4 million in Q3 2024 and bottomed at -$16.6 million in Q3 2022.
• The 5-year median for Free Cash Flow is $62.4 million (2023), against an average of $61.3 million.
• The widest annual swing landed in 2022, when Free Cash Flow slumped 108.47%; it then soared 423.42% in 2023.
• Tracing BIO-B's Free Cash Flow over 5 years: stood at $44.8 million in 2022, then decreased by 13.52% to $38.7 million in 2023, then surged by 109.87% to $81.3 million in 2024, then jumped by 46.49% to $119.1 million in 2025, then sank by 34.42% to $78.1 million in 2026.
• Per Business Quant, the three latest BIO-B Free Cash Flow figures stand at $78.1 million (Q1 2026), $119.1 million (Q4 2025), and $89.2 million (Q3 2025).

Peer Comparison